EUVIMEDEUVIMED entdecken
Open Access

EUS-guided fine needle aspiration-based clues to mistaken or uncertain identity: serous pancreatic cysts

Michele T Yip-Schneider, Rodica Muraru, Rachel C Kim, Howard H Wu, Stuart Sherman, Aditya Gutta, Mohammad A Al-Haddad, John M Dewitt, C Max Schmidt

HPB · 2023

DOI: 10.1016/j.hpb.2023.09.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HPB, 2023. Verfasst von Michele T Yip-Schneider und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA; Walther Oncology Center, Indianapolis, IN, USA; Indiana Universi…. Hauptthemen laut MEDLINE: Pancreatic Cyst, Pancreatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCRR NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/OBJECTIVES: Pancreatic serous cystic neoplasms (SCN) present a diagnostic challenge given their increasing frequency of detection and benign nature yet relatively high rate of misdiagnosis. Here, imaging and analyses associated with EUS-guided fine-needle aspiration (EUS-FNA) are evaluated for their ability to provide a correct preoperative diagnosis of SCN. METHODS: A surgical cohort with confirmed pathological diagnosis of SCN (n = 62) and a surveillance cohort with likely SCN (n = 31) were assessed for imaging (CT/MRI/EUS) and EUS-FNA-based analyses (cytology/DNA analysis for Von Hippel-Lindau [VHL] gene alterations/biomarkers). RESULTS: In the surgical cohort, CT/MRI and EUS respectively predicted SCN in 4 of 58(7%) and 19 of 62(31%). Cyst fluid cytology and VHL alterations predicted SCN in 1 of 51(2%) and 5 of 21(24%), respectively. High specificity cyst fluid biomarkers (vascular endothelial growth factor [VEGF]/glucose/carcinoembryonic antigen [CEA]/amylase) correctly identified SCN in 25 of 27(93%). In the surveillance cohort, cyst fluid biomarkers predicted SCN in 12 of 12(100%) while VHL alterations identified SCN 3 of 10(30%). CONCLUSION: High specificity cyst fluid biomarkers provided the most sensitive means of diagnosing SCN preoperatively. To obtain a preoperative diagnosis of SCN at the highest level of certainty, a multidisciplinary approach should be taken to inform appropriate SCN management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic CystPancreatic NeoplasmsHumansBiopsy, Fine-NeedleVascular Endothelial Growth Factor ACarcinoembryonic AntigenEndosonographyEndoscopic Ultrasound-Guided Fine Needle Aspiration

Substanzen

Vascular Endothelial Growth Factor ACarcinoembryonic Antigen

Autor:innen und Institutionen

  • Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA; Walther Oncology Center, Indianapolis, IN, USA; Indiana University Simon Cancer Center, Indianapolis, IN, USA; Indiana University Heal…
  • Center for Outcomes Research in Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Department of Medicine, Division of Gastroenterology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Biochemistry/Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA; Walther Oncology Center, I…

Förderung

  • NCRR NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • Indiana Clinical and Translational Sciences Institute
  • National Institutes of Health
  • National Center for Research Resources

Zitieren

APA

Yip-Schneider, M. T., Muraru, R., Kim, R. C., Wu, H. H., Sherman, S., Gutta, A., Al-Haddad, M. A., Dewitt, J. M., & Schmidt, C. M. (2023). EUS-guided fine needle aspiration-based clues to mistaken or uncertain identity: serous pancreatic cysts. HPB. https://doi.org/10.1016/j.hpb.2023.09.009

Vancouver

Yip-Schneider MT, Muraru R, Kim RC, Wu HH, Sherman S, Gutta A, et al. EUS-guided fine needle aspiration-based clues to mistaken or uncertain identity: serous pancreatic cysts. HPB. 2023. doi:10.1016/j.hpb.2023.09.009

BibTeX
@article{YipSchneider2023,
  author = {Yip-Schneider, Michele T and Muraru, Rodica and Kim, Rachel C and Wu, Howard H and Sherman, Stuart and Gutta, Aditya and Al-Haddad, Mohammad A and Dewitt, John M and Schmidt, C Max},
  title = {EUS-guided fine needle aspiration-based clues to mistaken or uncertain identity: serous pancreatic cysts},
  journal = {HPB},
  year = {2023},
  doi = {10.1016/j.hpb.2023.09.009}
}
Kostenlos starten →